Stock Valuation / CL
Is Colgate-Palmolive Company (CL) Overvalued? Fair Value & 5-Year Target
Colgate-Palmolive Company trades at $89.95 (P/E 35.55). Our reference model estimates a fair value of $63.28 at its recent average P/E of 25.01.
| Current price | $89.95 |
|---|---|
| Current EPS | $2.53 |
| Current P/E | 35.55 |
| Average P/E | 25.01 |
| Fair value (at avg P/E) | $63.28 |
| Upside to fair value | -29.6% |
| Illustrative 5-yr target (25× P/E, 15% growth) | $127.22 |
What drives CL's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA
Frequently asked questions
What is CL's fair value?
At its recent average P/E of 25.01, Colgate-Palmolive Company (CL) has a reference fair value of about $63.28, which is -29.6% versus the current price of $89.95.
Is Colgate-Palmolive Company (CL) overvalued or undervalued?
Based on the average-P/E reference model, Colgate-Palmolive Company looks overvalued relative to fair value by roughly +29.6%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
What is a 5-year price target for CL?
Under an illustrative model of 25× P/E and 15% annual EPS growth, the implied 5-year target is $127.22. Adjust both inputs on the interactive page to match your assumptions.
Open the interactive CL valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.